65,437 trials
Genitourinary System; Disorder, Female · Burning Vagina · Dyspareunia
Primary: Patient Global Impression of Improvement (PGI-I) Score at 4 Weeks After Initial Treatment — 2.66 score on a scale
Dermatological Non-Disease
Primary: Change in Waist Circumference — -1.87 cm — p=<0.0001
Aphasia · Primary Progressive Aphasia · Dementia
Primary: Change in Communication Confidence (CCRSA) — 64.32; 65.91; 63.00; 64.77 score on a scale
Stress Disorders, Post-Traumatic
Primary: Incidence of Recruitment of Study Participants — 19 participants
Neisseria Gonorrhoeae Infection · Chlamydia Trachomatis Infection
Primary: Incidence Rate of Ng Plus Ct Detected at Any Site Whilst Individuals Are Screened vs. Not Screened — 0.155; 0.205 Ng or CT cases per study visit
Ureter Obstruction
Primary: Percentage of Implanted Stents Meeting the Technical Success Criteria — 242; 158; 4; 2 Stent Implanted
Stroke
Primary: All-cause Mortality at 1 Year (Percentage of Patients With Modified Rankin Scale (mRS) Score =6) — 11.1; 12.2 Percentage of Participants — p=0.183
Total Knee Arthroplasty · Osteoarthritis
Primary: Free-living Daily Step Count — 6947; 6339 step count — p=0.024
Myopia
Primary: Annualized Changes in Refractive Error (SER) — -0.70; -0.66 Dioptre/year
Invasive Breast Cancer
Primary: DNA From the Germline and Breast Tumor for the Identification of Novel Somatic Changes Within Gene and Gene Pathways. — 3 mutations
Healthy Volunteers
Primary: Resting Energy Expenditure at Low Temperature — 1.277; 1.134; 1.300; 1.271 kcal/min
Atrial Fibrillation
Primary: Percentage of Participants With Primary Adverse Events (PAEs) — 0.0; 0.0; 1.5; 1.5 percentage of participants
Major Depressive Disorder
Primary: Change From Baseline to Week 6 in the MADRS Total Score — -9.03; -7.25 score on a scale — p=0.0568
Acute Myeloid Leukemia · FLT3-mutated Acute Myeloid Leukemia
Primary: Phase 1 Part: Maximum Tolerated Dose (MTD) of Gilteritinib — NA miligram (mg)
Malignant Female Reproductive System Neoplasm
Primary: Overall Benefit of Analgesia Score (OBAS) — 4; 4 score on a scale